Compare SOLS & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOLS | HSIC |
|---|---|---|
| Founded | 2025 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.0B |
| IPO Year | 2025 | 1996 |
| Metric | SOLS | HSIC |
|---|---|---|
| Price | $61.35 | $90.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 16 |
| Target Price | $79.25 | ★ $85.07 |
| AVG Volume (30 Days) | ★ 2.8M | 898.1K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.39% | N/A |
| EPS Growth | N/A | ★ 7.21 |
| EPS | 1.28 | ★ 1.74 |
| Revenue | $3,886,000,000.00 | ★ $13,201,995,000.00 |
| Revenue This Year | $6.36 | $6.12 |
| Revenue Next Year | $5.64 | $3.64 |
| P/E Ratio | ★ $47.65 | $51.95 |
| Revenue Growth | 3.08 | ★ 5.94 |
| 52 Week Low | $40.43 | $61.97 |
| 52 Week High | $90.80 | $92.18 |
| Indicator | SOLS | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 51.71 | 59.84 |
| Support Level | $60.06 | $87.67 |
| Resistance Level | $63.65 | $91.86 |
| Average True Range (ATR) | 2.17 | 1.74 |
| MACD | 0.77 | -0.12 |
| Stochastic Oscillator | 53.79 | 68.91 |
Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.